Gabapentin Tablet
Product Images NDC 50090-7715

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 01)

FDA Label Image

Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 02)

Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 02)
This is a description of a clinical trial design involving two periods: a titration period where participants receive gradually increasing doses of medication, and a fixed dose period lasting four weeks. The study includes a placebo group and a group receiving a high dose of Gabapentin at 3600 mg/day. The evaluation is conducted over multiple weeks.*
FDA Label Image

Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 03)

Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 03)
This text provides information about a study on pain management, specifically comparing the effects of placebo, 1800 mg/day of Gabapentin, and 2400 mg/day of Gabapentin over a 3-week dose titration period followed by a 4-week fixed dose period. It mentions a baseline measurement and a mean pain score.*
FDA Label Image

Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 04)

Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 04)
This text provides data on the proportion of responders in controlled post-herpetic neuralgia (PHN) studies. It compares the percentage of patients experiencing a 50% reduction in pain score after treatment with different dosages of gabapentin (GBP) versus placebo. Study 1 shows a 34% response rate for GBP 3600 and 52% for GBP 800, while Study 2 indicates response rates of 50% for GBP 800 and 64% for GBP 2400. The text also notes statistical significance with p-values provided.*
FDA Label Image

Image (E4b713f1 A833 4fc7 8a0f 696077ddc280 05)

FDA Label Image

Label Image (Lbl500907715)

Label Image (Lbl500907715)
This text is not readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.